OTCConsumer StaplesHousehold & Personal ProductsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for ADTI yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Successful integration of Levelution Sports Agency | Adapti completed the acquisition of Levelution Sports Agency in April 2026. | Intact | Failure to integrate Levelution or no revenue contribution by FY27 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextNewly stated in 2026-Q2 with the announcement of the acquisition completion on April 1, 2026. No direct financial impact data provided in the disclosures. The priority is newly delivered as the acquisition closed, marking a strategic expansion in athlete representation. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, loss-making business with a volatile management record, rather than an established durable compounder. The thesis is in a watch state, and confidence in the evidence is low.
ADTI is valued at a premium to peers, with the valuation model pointing to optionality, or possible future value from uncertain opportunities. The evidence says the premium is not paired with the full combination of weak results and turbulent conditions, so the expectations gap remains hard to judge.
Near term, operating cash flow is a concern: it worsened from negative $57,070 in 2025-Q3 to negative $766,268 in 2026-Q3. The Levelution acquisition closed, but no direct financial impact is reported; a CFO resignation and a notice of non-reliance on previously issued financial statements add uncertainty. Risk recently rose to high, while the broader Consumer Staples backdrop is a tailwind.
Over the next one to three years, the thesis hinges on whether management improves operating cash flow and navigates executive and financial-reporting issues. Near term, weakening jobs data could deepen recession concerns, while continued strong results from sector bellwethers PG, UL, and CL could sustain sector support; weaker results from those companies could remove that support.
ADTI’s multi-year view is uncertain: a supportive sector backdrop is set against weak results, rising risk, and limited evidence that the acquisition will improve finances. The thesis depends on better cash-flow execution and clearer evidence of progress. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Manage dilution and financial obligations from equity sales | A supporting condition in Adapti Inc's published investment case. The stated target is No further unregistered equity sales and manageable debt levels over next 4 quarters. | Under Pressure | New unregistered equity sales or significant debt increase in next 4 quarters | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stabilize management team after CFO departure | A primary condition in Adapti Inc's published investment case. The stated target is No further key executive departures and improved management communication by next 4 quarters. | Under Pressure | Additional key executive departures or worsening communication within next 4 quarters | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.